Development of alopecia in patients treated with interleukin-17 inhibitors

Dermatol Ther. 2020 Nov;33(6):e14527. doi: 10.1111/dth.14527. Epub 2020 Nov 22.

Authors

Layal Antoury¹, Nolan Maloney¹, Kyle Cheng¹

Affiliation

¹ Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.

PMID: 33174319
DOI: 10.1111/dth.14527

No abstract available

Publication types

Letter

MeSH terms

Alopecia Areata
Alopecia* / chemically induced
Alopecia* / diagnosis
Alopecia* / drug therapy
Humans
Immunosuppressive Agents
Interleukin-17*

Substances

Immunosuppressive Agents
Interleukin-17